nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.664	1	CbGbCtD
Zileuton—Traumatic liver injury—Riluzole—amyotrophic lateral sclerosis	0.0276	0.138	CcSEcCtD
Zileuton—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.0207	0.103	CcSEcCtD
Zileuton—EPHX2—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.016	0.12	CbGpPWpGaD
Zileuton—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0122	0.061	CcSEcCtD
Zileuton—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0104	0.052	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.00985	0.0743	CbGpPWpGaD
Zileuton—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00903	0.045	CcSEcCtD
Zileuton—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00876	0.0437	CcSEcCtD
Zileuton—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00562	0.028	CcSEcCtD
Zileuton—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0056	0.0279	CcSEcCtD
Zileuton—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0054	0.027	CcSEcCtD
Zileuton—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00517	0.0258	CcSEcCtD
Zileuton—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00444	0.0221	CcSEcCtD
Zileuton—Tension—Riluzole—amyotrophic lateral sclerosis	0.00442	0.022	CcSEcCtD
Zileuton—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00437	0.0218	CcSEcCtD
Zileuton—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00418	0.0208	CcSEcCtD
Zileuton—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00406	0.0202	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.00385	0.029	CbGpPWpGaD
Zileuton—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00383	0.0191	CcSEcCtD
Zileuton—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00383	0.0191	CcSEcCtD
Zileuton—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00383	0.0191	CcSEcCtD
Zileuton—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00379	0.0189	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00335	0.0167	CcSEcCtD
Zileuton—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0166	CcSEcCtD
Zileuton—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00327	0.0163	CcSEcCtD
Zileuton—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.0161	CcSEcCtD
Zileuton—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00317	0.0158	CcSEcCtD
Zileuton—Pain—Riluzole—amyotrophic lateral sclerosis	0.00314	0.0157	CcSEcCtD
Zileuton—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00314	0.0157	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.00314	0.0236	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.0031	0.0234	CbGpPWpGaD
Zileuton—EPHX2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00304	0.0229	CbGpPWpGaD
Zileuton—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00303	0.0151	CcSEcCtD
Zileuton—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00292	0.0146	CcSEcCtD
Zileuton—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.0029	0.0145	CcSEcCtD
Zileuton—EPHX2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00275	0.0208	CbGpPWpGaD
Zileuton—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00271	0.0135	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00266	0.02	CbGpPWpGaD
Zileuton—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0026	0.013	CcSEcCtD
Zileuton—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00251	0.0125	CcSEcCtD
Zileuton—Tiaprofenic acid—PTGS2—amyotrophic lateral sclerosis	0.00245	1	CrCbGaD
Zileuton—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0121	CcSEcCtD
Zileuton—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00234	0.0116	CcSEcCtD
Zileuton—Rash—Riluzole—amyotrophic lateral sclerosis	0.00232	0.0116	CcSEcCtD
Zileuton—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0115	CcSEcCtD
Zileuton—Headache—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0115	CcSEcCtD
Zileuton—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0109	CcSEcCtD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00212	0.016	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00202	0.0153	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00194	0.0146	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0018	0.0136	CbGpPWpGaD
Zileuton—ALOX5—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	0.00172	0.0129	CbGpPWpGaD
Zileuton—EPHX2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00172	0.0129	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.0017	0.0128	CbGpPWpGaD
Zileuton—ALOX5—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00169	0.0128	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.0016	0.0121	CbGpPWpGaD
Zileuton—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.0016	0.0121	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00142	0.0107	CbGpPWpGaD
Zileuton—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00135	0.0101	CbGpPWpGaD
Zileuton—EPHX2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00122	0.00916	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.0012	0.00905	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00118	0.00889	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00116	0.00876	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00115	0.00868	CbGpPWpGaD
Zileuton—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00115	0.00867	CbGpPWpGaD
Zileuton—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—amyotrophic lateral sclerosis	0.00115	0.00864	CbGpPWpGaD
Zileuton—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.0011	0.00833	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00108	0.00815	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00108	0.00813	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.001	0.00756	CbGpPWpGaD
Zileuton—ALOX5—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000954	0.00719	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000945	0.00712	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000945	0.00712	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000943	0.00711	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000942	0.0071	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	0.000897	0.00677	CbGpPWpGaD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000888	0.00669	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000881	0.00664	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000864	0.00651	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000863	0.00651	CbGpPWpGaD
Zileuton—UGT1A9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000815	0.00614	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000803	0.00605	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000801	0.00604	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000757	0.00571	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000755	0.00569	CbGpPWpGaD
Zileuton—PTGS1—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	0.000744	0.00561	CbGpPWpGaD
Zileuton—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000734	0.00553	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00069	0.0052	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000683	0.00515	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000646	0.00487	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000628	0.00473	CbGpPWpGaD
Zileuton—UGT1A9—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000623	0.0047	CbGpPWpGaD
Zileuton—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000623	0.00469	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00062	0.00467	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000611	0.00461	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000607	0.00458	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000574	0.00433	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000555	0.00419	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000534	0.00402	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000532	0.00401	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000525	0.00396	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000525	0.00396	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000521	0.00393	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000518	0.0039	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000514	0.00387	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000512	0.00386	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000502	0.00378	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00049	0.00369	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000481	0.00362	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000478	0.0036	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000472	0.00356	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000468	0.00353	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000447	0.00337	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000435	0.00328	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000435	0.00328	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000433	0.00326	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00042	0.00317	CbGpPWpGaD
Zileuton—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00042	0.00316	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000416	0.00313	CbGpPWpGaD
Zileuton—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000414	0.00312	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000409	0.00308	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000407	0.00307	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000392	0.00296	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000386	0.00291	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000386	0.00291	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—DAO—amyotrophic lateral sclerosis	0.00038	0.00286	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000374	0.00282	CbGpPWpGaD
Zileuton—UGT1A9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000365	0.00275	CbGpPWpGaD
Zileuton—UGT1A9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00036	0.00271	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000358	0.0027	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000349	0.00263	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000344	0.00259	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000332	0.0025	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00033	0.00249	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000328	0.00247	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000298	0.00225	CbGpPWpGaD
Zileuton—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000297	0.00224	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000288	0.00217	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00028	0.00211	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000279	0.00211	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000279	0.00211	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000274	0.00207	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000269	0.00203	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000267	0.00201	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000266	0.002	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000263	0.00198	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000261	0.00196	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000256	0.00193	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000246	0.00185	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000245	0.00185	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000242	0.00183	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000242	0.00182	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000238	0.00179	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00023	0.00174	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00023	0.00173	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000229	0.00172	CbGpPWpGaD
Zileuton—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000228	0.00172	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000228	0.00172	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000228	0.00172	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000225	0.0017	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000223	0.00168	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000218	0.00164	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000218	0.00164	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000215	0.00162	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000212	0.0016	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000211	0.00159	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000211	0.00159	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00021	0.00158	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000208	0.00157	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000202	0.00152	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000201	0.00152	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000199	0.0015	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000199	0.0015	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000195	0.00147	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000194	0.00146	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000194	0.00146	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000186	0.0014	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000184	0.00138	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000182	0.00137	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000172	0.0013	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000165	0.00124	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000162	0.00122	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000159	0.0012	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000157	0.00118	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000156	0.00118	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000154	0.00116	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000153	0.00115	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000147	0.00111	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000143	0.00108	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000141	0.00107	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000136	0.00103	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000134	0.00101	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000133	0.001	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000132	0.000993	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000129	0.00097	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000126	0.000949	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000125	0.000941	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00012	0.000903	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00012	0.000903	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000117	0.000884	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000116	0.000875	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000115	0.000868	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000112	0.000842	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.00011	0.00083	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00011	0.000826	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000109	0.000823	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000108	0.000812	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000106	0.000798	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000105	0.000791	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000103	0.000777	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000102	0.000772	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000102	0.000772	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000102	0.000768	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000102	0.000766	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	9.57e-05	0.000722	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.54e-05	0.000719	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.46e-05	0.000713	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	9.36e-05	0.000706	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—APOE—amyotrophic lateral sclerosis	8.87e-05	0.000668	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.7e-05	0.000656	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	8.66e-05	0.000653	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.63e-05	0.000651	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.48e-05	0.000639	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	8.18e-05	0.000617	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.01e-05	0.000604	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7.9e-05	0.000595	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7.9e-05	0.000595	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	7.4e-05	0.000558	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.26e-05	0.000547	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	7.22e-05	0.000545	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.19e-05	0.000542	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.72e-05	0.000506	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	6.56e-05	0.000495	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	6.31e-05	0.000476	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.24e-05	0.00047	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.07e-05	0.000458	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	6.06e-05	0.000457	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.91e-05	0.000446	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.73e-05	0.000432	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.71e-05	0.00043	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.61e-05	0.000423	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.52e-05	0.000416	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.44e-05	0.00041	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	5.18e-05	0.00039	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.08e-05	0.000383	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.97e-05	0.000375	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—APOE—amyotrophic lateral sclerosis	4.72e-05	0.000355	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.71e-05	0.000355	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.67e-05	0.000352	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.54e-05	0.000342	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.33e-05	0.000326	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.25e-05	0.00032	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.99e-05	0.000301	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.88e-05	0.000292	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	3.84e-05	0.00029	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.28e-05	0.000247	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.23e-05	0.000244	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.11e-05	0.000234	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.67e-05	0.000201	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.66e-05	0.0002	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.63e-05	0.000199	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.46e-05	0.000185	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.28e-05	0.000172	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.1e-05	0.000158	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.02e-05	0.000152	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.76e-05	0.000133	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.73e-05	0.00013	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000122	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.38e-05	0.000104	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.33e-05	0.0001	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.18e-05	8.92e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.13e-06	6.88e-05	CbGpPWpGaD
